Literature DB >> 10729387

Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia.

F R Leus1, M E Wittekoek, J Prins, J J Kastelein, H A Voorbij.   

Abstract

Human serum paraoxonase (PON) is a high density lipoprotein (HDL) associated enzyme capable of hydrolyzing lipid peroxides in vitro. PON has recently attracted attention as a protective factor against oxidative modification of LDL and may therefore play an important role in the prevention of the atherosclerotic process. Two frequent mutations at the paraoxonase gene locus (PON1) are the leucine (L allele)-->methionine (M allele) and the glutamine (Q allele)-->arginine (R allele) substitutions at residues 55 and 192, respectively. We have examined the influence of these two polymorphisms on carotid atherosclerosis in familial hypercholesterolemia (FH) patients. The allele frequencies of these two polymorphisms were determined by PCR and restriction fragment analysis, for both the FH population and healthy controls. High resolution B-mode ultrasound was used to assess intima-media wall thickness (IMT) of the carotid artery. No differences were found in allele frequencies between the FH and the control population. In FH patients, the LL, LM and MM genotypes at position 55 occurred in 86 (46.0%), 78 (41.7%) and 23 (12.3%) subjects, respectively, whereas the QQ, QR and RR genotypes at position 192 were found in 90 (48.1%), 79 (42.2%) and 18 (9.6%) individuals. When both polymorphisms were considered separately, no different carotid IMTs were found between the genotype groups. However, our data did show a significant association between the various genotypes of the combined polymorphisms at position 55 and 192 of PON1 and the carotid artery IMT in FH subjects. Subjects with the homozygous wildtype LL/QQ for paraoxonase had the highest mean carotid IMTs when compared to other genotypes, combined. Multiple regression analysis demonstrated age (beta=0.34, P<0.0001), total plasma cholesterol (beta=0.17, P=0. 0109) and the LL/QQ genotype of the PON1 gene (beta=0.22, P=0.0018) to be significant risk factors for carotid atherosclerosis in subjects with FH. The LL/QQ genotype could explain 5.3% of total variance of carotid IMT. In conclusion, this is the first study to report an independent association between the combined PON1 polymorphism genotypes and carotid wall thickness. The homozygous wildtype LL/QQ for PON1 may represent an additional risk factor for carotid atherosclerosis in subjects with FH.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729387     DOI: 10.1016/s0021-9150(99)00324-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Paraoxonase (PON)1 192R allele carriage is associated with reduced risk of inflammatory bowel disease.

Authors:  Amir Karban; Corina Hartman; Rami Eliakim; Matti Waterman; Shula Nesher; Ofra Barnett-Griness; Raanan Shamir
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

Review 2.  Gene activation regresses atherosclerosis, promotes health, and enhances longevity.

Authors:  Pauli V Luoma
Journal:  Lipids Health Dis       Date:  2010-07-06       Impact factor: 3.876

3.  p.Q192R SNP of PON1 seems not to be Associated with Carotid Atherosclerosis Risk Factors in an Asymptomatic and Normolipidemic Brazilian Population Sample.

Authors:  Daniel Zanetti Scherrer; Vanessa Helena de Souza Zago; Isabela Calanca Vieira; Eliane Soler Parra; Natália Baratella Panzoldo; Fernanda Alexandre; Rodrigo Secolin; Jamal Baracat; Eder Carlos Rocha Quintão; Eliana Cotta de Faria
Journal:  Arq Bras Cardiol       Date:  2015-05-29       Impact factor: 2.000

Review 4.  Paraoxonase 1 gene polymorphisms in lipid oxidation and atherosclerosis development.

Authors:  Marija Vavlukis; Ana Vavlukis; Katerina Krsteva; Sonja Topuzovska
Journal:  Front Genet       Date:  2022-09-02       Impact factor: 4.772

5.  Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.

Authors:  Rakesh S Birjmohun; Menno Vergeer; Erik S G Stroes; Manjinder S Sandhu; Sally L Ricketts; Michael W Tanck; Nicholas J Wareham; J Wouter Jukema; John J P Kastelein; Kay-Tee Khaw; S Matthijs Boekholdt
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

6.  Evaluation of single nucleotide polymorphisms in 6 candidate genes and carotid intima-media thickness in community-dwelling residents.

Authors:  Fang-Yang Wu; Chia-Ing Li; Li-Na Liao; Chiu-Shong Liu; Wen-Yuan Lin; Chih-Hsueh Lin; Chuan-Wei Yang; Tsai-Chung Li; Cheng-Chieh Lin
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.